Abstract
Objectives:
To assess the antidiabetic potential of
Shilajatvadi Lauha
(SL) processed with
Daruharidra
(modified SL [MSL]) in streptozotocin (STZ)-nicotinamide (NA)-induced diabetic rats.
Materials and Methods:
Animals were divided into diabetic and nondiabetic groups. Type 2 diabetes in rats was induced with a single dose of STZ (65 mg/kg) NA (110 mg/kg) intraperitoneal diabetic rats were treated with formulation MSL (10, 30, and 100 mg/kg) and glibenclamide (10 mg/kg) once daily for 14 days orally. After 14 days treatment, fasting blood glucose and plasma insulin were assayed. Different biochemical parameters such as total cholesterol (TC), triglycerides (TGs), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), and very LDL-C (VLDL-C) were also examined.
Results:
MSL significantly lowered the blood glucose and increases insulin level, which was comparable to the standard antidiabetic drug, glibenclamide. Treatment with MSL showed a significantly reduction in the levels of TC, TG, LDL-C, and VLDL-C and increases the level of HDL-C.
Conclusion:
MSL possess significant antidiabetic and antihyperlipidemic activity in Type 2 diabetes mellitus rats. The results are encouraging and further studies can be used to evaluate the exact mechanism of action to develop a novel molecule that will benefit the ailing.
Recommended Citation
Singh, Thakur Rakesh; Gupta, Laxmi Narayan; Kumar, Neeraj; and Kumar, Vikas
(2016)
"Assessment of antidiabetic potential of,"
Indian Journal of Health Sciences and Biomedical Research KLEU: Vol. 9:
Iss.
3, Article 13.
DOI: https://doi.org/10.4103/2349-5006.196334
Available at:
https://kleijhsbr.researchcommons.org/journal/vol9/iss3/13
Pages
308
Last Page
314
Copyright
© 2016 Indian Journal of Health Sciences and Biomedical Research KLEU | Published by Wolters Kluwer – Medknow